Abstract: The invention relates to gram-negative bacteria carrying gene-inactivating mutations that cause deletion of proteins belonging to the OMV proteome, to Outer Membrane Vesicles (OMVs) produced by these bacteria and immunogenic compositions thereof.
Type:
Grant
Filed:
April 16, 2020
Date of Patent:
February 17, 2026
Assignee:
BIOMVIS SRL
Inventors:
Guido Grandi, Alberto Grandi, Laura Fantappie', Ilaria Zanella, Enrico Koenig, Assunta Gagliardi
Abstract: There are disclosed fusion proteins comprising the bacterial protein FhuD2 and one or more copies of a heterologous polypeptide, polynucleotides and expression vectors encoding the fusion proteins and bacterial outer membrane vesicles containing them. Other aspects of the invention regard immunogenic compositions comprising the outer membrane vesicles and their use in the prevention or treatment of tumors.
Abstract: There is disclosed a method for the co-expression of multi-antigens in bacterial outer membrane vesicles, immunogenic compositions containing the isolated vesicles and the use thereof for the prevention or treatment of bacterial infections.
Type:
Application
Filed:
October 19, 2021
Publication date:
December 7, 2023
Applicant:
BIOMVIS SRL
Inventors:
Assunta Gagliardi, Alberto Grandi, Laura Fantappie'
Abstract: The present invention provides means and products for the stimulation of an immune response against tumors in a subject in need thereof. More specifically the invention provides immunogenic compositions containing bacterial outer membrane vesicles loaded with tumor antigens, fusion proteins comprising a bacterial protein and a tumor antigen, and isolated bacterial outer membrane vesicles (OMVs) containing said fusion proteins. The fusion proteins, OMVs and immunogenic compositions according to the invention are used in the prevention and treatment of tumors.
Type:
Grant
Filed:
May 17, 2016
Date of Patent:
July 20, 2021
Assignee:
BIOMVIS SRL
Inventors:
Guido Grandi, Valeria Cafardi, Laura Fantappieā², Renata Grifantini, Alberto Grandi
Abstract: This invention relates to outer membrane vesicles (OMVs) from Gram-negative bacteria. The vesicles comprise heterologous proteins or immunogenic fragments thereof expressed as lipoproteins in their membrane. The OMVs of the invention are capable of eliciting an immune response to the heterologous protein or to a fragment thereof when administered to a mammal. Other aspects of the invention relate to methods of preparing the OMVs and immunogenic compositions containing the same.
Type:
Grant
Filed:
October 23, 2017
Date of Patent:
June 8, 2021
Assignee:
BIOMVIS SRL
Inventors:
Guido Grandi, Laura Fantappie', Carmela Irene
Abstract: There are disclosed fusion proteins comprising the bacterial protein FhuD2 and one or more copies of a heterologous polypeptide, polynucleotides and expression vectors encoding the fusion proteins and bacterial outer membrane vesicles containing them. Other aspects of the invention regard immunogenic compositions comprising the outer membrane vesicles and their use in the prevention or treatment of tumors.